Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

DGAP-News: Deutsche Industrie REIT-AG erwirbt Light Industrial Objekte in Damsdorf, Dinslaken und Wedemark
DGAP-News: Deutsche Industrie REIT-AG erwirbt Light Industrial Objekte in Damsdorf, Dinslaken und Wedemark
DGAP-News: Deutsche Industrie REIT-AG erwirbt Light Industrial Objekte in Damsdorf, Dinslaken und Wedemark
DGAP-News: Dermapharm Holding SE treibt Unternehmenswachstum im dritten Quartal 2019 weiter voran
DGAP-News: Dermapharm Holding SE treibt Unternehmenswachstum im dritten Quartal 2019 weiter voran
DGAP-News: Dermapharm Holding SE treibt Unternehmenswachstum im dritten Quartal 2019 weiter voran
DGAP-News: Dermapharm Holding SE continues to drive the company's growth in the third quarter of 2019
DGAP-News: Dermapharm Holding SE continues to drive the company's growth in the third quarter of 2019
DGAP-News: Dermapharm Holding SE continues to drive the company's growth in the third quarter of 2019
DGAP-News: Deutsche Industrie REIT-AG legt das Volumen für Kapitalerhöhung fest
DGAP-News: Deutsche Industrie REIT-AG legt das Volumen für Kapitalerhöhung fest
DGAP-News: Deutsche Industrie REIT-AG legt das Volumen für Kapitalerhöhung fest
DGAP-News: Deutsche Industrie REIT-AG sets volume of capital increase
DGAP-News: Deutsche Industrie REIT-AG sets volume of capital increase
DGAP-News: Deutsche Industrie REIT-AG sets volume of capital increase
DGAP-Adhoc: Deutsche Industrie REIT-AG sells 100% of the shares from the capital increase
DGAP-Adhoc: Deutsche Industrie REIT-AG sells 100% of the shares from the capital increase
DGAP-Adhoc: Deutsche Industrie REIT-AG sells 100% of the shares from the capital increase
DGAP-Adhoc: Deutsche Industrie REIT-AG: 100 % der Aktien der Deutsche Industrie REIT-AG aus der Kapitalerhöhung platziert
DGAP-Adhoc: Deutsche Industrie REIT-AG: 100 % der Aktien der Deutsche Industrie REIT-AG aus der Kapitalerhöhung platziert
DGAP-Adhoc: Deutsche Industrie REIT-AG: 100 % der Aktien der Deutsche Industrie REIT-AG aus der Kapitalerhöhung platziert
DGAP-News: Deutsche Industrie REIT-AG - Preliminary subscription quota: 44.6 % of the new shares subscribed for in the subscription offer - Start of private placement
DGAP-News: Deutsche Industrie REIT-AG - Preliminary subscription quota: 44.6 % of the new shares subscribed for in the subscription offer - Start of private placement
DGAP-News: Deutsche Industrie REIT-AG - Preliminary subscription quota: 44.6 % of the new shares subscribed for in the subscription offer - Start of private placement
DGAP-News: Deutsche Industrie REIT-AG - Vorläufige Bezugsrechtsquote 44,6 % der neuen Aktien der im Rahmen des Bezugsangebots bezogen - Beginn der Privatplatzierung
DGAP-News: Deutsche Industrie REIT-AG - Vorläufige Bezugsrechtsquote 44,6 % der neuen Aktien der im Rahmen des Bezugsangebots bezogen - Beginn der Privatplatzierung
DGAP-News: Deutsche Industrie REIT-AG - Vorläufige Bezugsrechtsquote 44,6 % der neuen Aktien der im Rahmen des Bezugsangebots bezogen - Beginn der Privatplatzierung
DGAP-Adhoc: Deutsche Industrie REIT-AG sets subscription price at EUR 16.25 per new share
DGAP-Adhoc: Deutsche Industrie REIT-AG sets subscription price at EUR 16.25 per new share
DGAP-Adhoc: Deutsche Industrie REIT-AG sets subscription price at EUR 16.25 per new share
DGAP-Adhoc: Deutsche Industrie REIT-AG legt Bezugspreis auf EUR 16,25 je neuer Aktie fest
DGAP-Adhoc: Deutsche Industrie REIT-AG legt Bezugspreis auf EUR 16,25 je neuer Aktie fest
DGAP-Adhoc: Deutsche Industrie REIT-AG legt Bezugspreis auf EUR 16,25 je neuer Aktie fest
DGAP-Adhoc: Deutsche Industrie REIT-AG beschließt Kapitalerhöhung aus genehmigtem Kapital
DGAP-Adhoc: Deutsche Industrie REIT-AG beschließt Kapitalerhöhung aus genehmigtem Kapital
DGAP-Adhoc: Deutsche Industrie REIT-AG beschließt Kapitalerhöhung aus genehmigtem Kapital
DGAP-Adhoc: Deutsche Industrie REIT-AG resolves capital increase from authorized capital
DGAP-Adhoc: Deutsche Industrie REIT-AG resolves capital increase from authorized capital
DGAP-Adhoc: Deutsche Industrie REIT-AG resolves capital increase from authorized capital
EQS-News: Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges
EQS-News: Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges
EQS-News: Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges
EQS-News: Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business
EQS-News: Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business
EQS-News: Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business
EQS-News: Dermapharm Holding SE builds on success in Q3 2023
EQS-News: Dermapharm Holding SE builds on success in Q3 2023
EQS-News: Dermapharm Holding SE builds on success in Q3 2023
EQS-News: Dermapharm Holding SE publishes  H1 2023 financial report,  confirms outlook for 2023 overall
EQS-News: Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall
EQS-News: Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall
EQS-News: Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment
EQS-News: Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment
EQS-News: Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment
EQS-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 1.05 per share
EQS-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 1.05 per share
EQS-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 1.05 per share
EQS-News: Dermapharm Holding SE invests in family-owned Austrian pharmaceutical company Montavit
EQS-News: Dermapharm Holding SE invests in family-owned Austrian pharmaceutical company Montavit
EQS-News: Dermapharm Holding SE invests in family-owned Austrian pharmaceutical company Montavit
EQS-News: Dermapharm Holding SE:  outstanding start  to financial year 2023
EQS-News: Dermapharm Holding SE: outstanding start to financial year 2023
EQS-News: Dermapharm Holding SE: outstanding start to financial year 2023
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory
EQS-Adhoc: Dermapharm Holding SE: 2022 dividend
EQS-Adhoc: Dermapharm Holding SE: 2022 dividend
EQS-Adhoc: Dermapharm Holding SE: 2022 dividend
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE's revenue exceeds one billion for the first time
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE's revenue exceeds one billion for the first time
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE's revenue exceeds one billion for the first time
EQS-News: Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma
EQS-News: Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma
EQS-News: Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma